		OMB APPROVAL
	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549	OMB Number: 3235-0060 Expires: March 31, 2014 Estimated average burden hours per response……………5.00
	FORM 8-K
	CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

	OMB APPROVAL
	OMB Number: 3235-0060 Expires: March 31, 2014 Estimated average burden hours per response……………5.00

February 14, 2012		000-30237
Date of Report (Date of earliest event reported)		Commission File Number

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934


May 11, 2012		000-30237
Date of Report (Date of earliest event reported)		Commission File Number

REGENECA, INC.

(Exact name of registrant as specified in its charter)


Nevada		88-0467241
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification Number)

1 Technology, Suite C515 Irvine, CA 92618
(Address of Principal Executive Offices) (Zip Code)

(949) 887-6890
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

. r Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

.r Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

.r Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

.r Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 51.0201. ~~Departure~~Entry ofinto ~~Directors~~a orMaterial ~~Certain~~Definitive ~~Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers~~Agreement.

~~Effective~~ On asMay ~~of February 14~~11, 2012, ~~Daniel~~Regeneca, RInc. ~~Kerker resigned as~~ (the ~~Chief Financial Officer/Treasurer of the~~ “Company.”) ~~There are no disagreements between the Company~~ and MrDwight D. ~~Kerker~~Baron, ~~and~~entered ~~his~~into ~~resignation~~a ~~did~~Settlement ~~not~~Agreement ~~state~~which ~~any~~is ~~reason~~attached ~~for~~hereto ~~his~~as ~~resignation.~~Exhibit 10.1.

The terms of the Settlement Agreement include the release of all claims Dwight D. Baron has or may have against the Company, including unpaid principal and interest on certain matured promissory notes in exchange for the Company’s assignment to Dwight D. Baron of all claims against former Company employee, Shirish Phulgaonkar, and all claimas against ChromaDex, Inc. relating to the testing of the Phulgaonkar products, and the rights, title and interest in and to, all formulas and other products and intellectual property created by Shirish Phulgaonkar during his tenure with the Company.

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 16, 2012, Dwight D. Baron, director of the Company, resigned from his position on the Board of Directors. There are no disagreements between the Company and Mr. Baron and his resignation did not state any reason for his resignation.

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

10.1 Settlement Agreement entered into with Dwight D. Baron, dated May 11, 2012.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	REGENECA, INC.
February 22, 2012		/s/ Matthew Nicosia
May 11, 2012		/s/ Matthew Nicosia
	Name:	Matthew Nicosia
	Title:	CEO, President and Chairman

Filing Compare · Regeneca, Inc.